Recent developments in adjuvants for vaccines against infectious diseases

This publication has 193 references indexed in Scilit:

• Human TH1 and TH2 subsets: doubt no more
  Published by Elsevier ,2004
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
  The Lancet, 2001
• QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
  Published by Elsevier ,2001
• A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
  Vaccine, 2000
• Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720
  Vaccine, 1997
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
• Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity
  Research in Immunology, 1992
• Immunological adjuvants: a role for liposomes
  Immunology Today, 1990
• CpG islands as gene markers in the vertebrate nucleus
  Trends in Genetics, 1987